A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).

BACKGROUND: Magnetic resonance imaging (MRI) acquisition/processing techniques assess brain volumes to explore neurodegeneration in Alzheimer's disease (AD). OBJECTIVE: We examined the clinical utility of MSmetrix and investigated if automated MRI volumes could discriminate between groups covering the AD continuum and could be used as a predictor for clinical progression. METHODS: The Belgian Dementia Council initiated a retrospective, multi-center study and analyzed whole brain (WB), grey matter (GM), white matter (WM), cerebrospinal fluid (CSF), cortical GM (CGM) volumes, and WM hyperintensi... Mehr ...

Verfasser: Niemantsverdriet, Ellis
Ribbens, Annemie
Bastin, Christine
Benoit, Florence
Bergmans, Bruno
Bier, Jean-Christophe
Bladt, Roxanne
Claes, Lene
De Deyn, Peter Paul
Deryck, Olivier
Hanseeuw, Bernard
Ivanoiu, Adrian
Lemper, Jean-Claude
Mormont, Eric
Picard, Gaëtane
Salmon, Eric
Segers, Kurt
Sieben, Anne
Smeets, Dirk
Struyfs, Hanne
Thiery, Evert
Tournoy, Jos
Triau, Eric
Vanbinst, Anne-Marie
Versijpt, Jan
Bjerke, Maria
Engelborghs, Sebastiaan
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Verlag/Hrsg.: IOS Press
Schlagwörter: Alzheimer’s disease / MSmetrix / Biomarkers / Magnetic resonance image / Volumetry
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26529807
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/198418